Income Statement Apple Inc.

Equities

AAPL

US0378331005

Phones & Handheld Devices

Market Closed - Nasdaq Other stock markets 21:00:00 12/12/2025 GMT			5-day change	1st Jan Change
278.28 ^USD	+0.09%		-0.18%	+11.13%

12-12	Broadcom's $73 Billion AI Backlog Over Next 6 Quarters Ahead of Investor Expectations, BofA Securities Says	MT
12-12	Apple Loses Epic Games Appeal, Wins Ability to Charge Commissions on Third-Party App Sales	MT

47c6c51cb2e.SkwinzFIcRj-Ujd8zs5YijmOEdUtXfvkNsR0YqimJpk.eA1PyGIrGyC5FVA2uZ0S0G25fpwYNM-0BIxZFMLkFskzCXDbRnwVQrwnYg

Published financial data: APPLE INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024	2025
Revenues	366B	394B	383B	391B	416B
Total Revenues	366B	394B	383B	391B	416B
Cost of Goods Sold, Total	213B	224B	214B	210B	221B
Gross Profit	153B	171B	169B	181B	195B
Selling General & Admin Expenses, Total	21.97B	25.09B	24.93B	26.1B	27.6B
R&D Expenses	21.91B	26.25B	29.92B	31.37B	34.55B
Other Operating Expenses, Total	43.89B	51.34B	54.85B	57.47B	62.15B
Operating Income	109B	119B	114B	123B	133B
Interest Expense, Total	-2.64B	-2.93B	-3.93B	-	-
Interest And Investment Income	2.84B	2.82B	3.75B	-	-
Net Interest Expenses	198M	-106M	-183M	-	-
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	60M	-228M	-382M	269M	-321M
EBT, Excl. Unusual Items	109B	119B	114B	123B	133B
Gain (Loss) On Sale Of Investments	-	-	-	-	-
EBT, Incl. Unusual Items	109B	119B	114B	123B	133B
Income Tax Expense	14.53B	19.3B	16.74B	29.75B	20.72B
Earnings From Continuing Operations	94.68B	99.8B	97B	93.74B	112B
Net Income to Company	94.68B	99.8B	97B	93.74B	112B
Net Income - (IS)	94.68B	99.8B	97B	93.74B	112B
Net Income to Common Incl Extra Items	94.68B	99.8B	97B	93.74B	112B
Net Income to Common Excl. Extra Items	94.68B	99.8B	97B	93.74B	112B
Per Share Items
Net EPS - Basic	5.67	6.15	6.16	6.11	7.49
Basic EPS - Continuing Operations	5.67	6.15	6.16	6.11	7.49
Basic Weighted Average Shares Outstanding	16.7B	16.22B	15.74B	15.34B	14.95B
Net EPS - Diluted	5.61	6.11	6.13	6.08	7.46
Diluted EPS - Continuing Operations	5.61	6.11	6.13	6.08	7.46
Diluted Weighted Average Shares Outstanding	16.86B	16.33B	15.81B	15.41B	15B
Normalized Basic EPS	4.09	4.59	4.51	5.03	5.55
Normalized Diluted EPS	4.05	4.56	4.5	5.01	5.53
Dividend Per Share	0.85	0.9	0.94	0.98	1.02
Payout Ratio	15.28	14.87	15.49	16.25	13.77
American Depositary Receipts Ratio (ADR)	0.05	0.05	0.05	0.05	0.05
Supplemental Items
EBITDA	120B	131B	126B	135B	145B
EBITA	109B	119B	114B	123B	133B
EBIT	109B	119B	114B	123B	133B
EBITDAR	135B	147B	142B	150B	163B
Total Revenues (As Reported)	366B	394B	383B	391B	416B
Effective Tax Rate - (Ratio)	13.3	16.2	14.72	24.09	15.61
Current Domestic Taxes	9.88B	9.41B	11.02B	7.3B	13.17B
Current Foreign Taxes	9.42B	9B	8.75B	25.48B	8.89B
Total Current Taxes	19.3B	18.4B	19.76B	32.78B	22.06B
Deferred Domestic Taxes	-7.51B	-2.18B	-3.69B	-3.38B	-1.94B
Deferred Foreign Taxes	2.74B	3.08B	669M	347M	604M
Total Deferred Taxes	-4.77B	895M	-3.02B	-3.03B	-1.34B
Normalized Net Income	68.25B	74.44B	71.08B	77.18B	82.96B
Interest on Long-Term Debt	2.6B	2.8B	3.7B	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	21.91B	26.25B	29.92B	31.37B	34.55B
Net Rental Expense, Total	14.6B	16.8B	15.9B	15.8B	18.2B
Imputed Operating Lease Interest Expense	2.39B	2.93B	3.9B	-	-
Imputed Operating Lease Depreciation	12.21B	13.87B	12B	-	-
Stock-Based Comp., COGS (Total)	-	-	-	-	-
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	7.91B	9.04B	10.83B	11.69B	12.86B
Total Stock-Based Compensation	7.91B	9.04B	10.83B	11.69B	12.86B

Fiscal Period: September	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	34.94B	23.65B	29.96B	29.94B	35.93B
Short Term Investments	27.7B	24.66B	31.59B	35.23B	18.76B
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	62.64B	48.3B	61.56B	65.17B	54.7B
Accounts Receivable, Total	26.28B	28.18B	29.51B	33.41B	39.78B
Other Receivables	25.23B	32.75B	31.48B	32.83B	33.18B
Total Receivables	51.51B	60.93B	60.98B	66.24B	72.96B
Inventory	6.58B	4.95B	6.33B	7.29B	5.72B
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	14.11B	21.22B	14.7B	14.29B	14.58B
Total Current Assets	135B	135B	144B	153B	148B
Gross Property Plant And Equipment	120B	125B	125B	119B	126B
Accumulated Depreciation	-70.28B	-72.34B	-70.88B	-73.45B	-76.01B
Net Property Plant And Equipment	49.53B	52.53B	54.38B	45.68B	49.83B
Long-term Investments	128B	121B	101B	91.48B	77.72B
Goodwill	-	-	-	-	-
Other Intangibles, Total	-	-	-	-	-
Deferred Tax Assets Long-Term	-	-	-	19.5B	20.78B
Other Long-Term Assets, Total	38.76B	44.01B	54.1B	55.34B	62.95B
Total Assets	351B	353B	353B	365B	359B
Liabilities
Accounts Payable, Total	54.76B	64.12B	62.61B	68.96B	69.86B
Accrued Expenses, Total	-	-	-	-	8.92B
Short-term Borrowings	6B	9.98B	5.98B	9.97B	7.98B
Current Portion of Long-Term Debt	9.61B	11.13B	9.82B	10.91B	12.35B
Current Portion of Leases	1.53B	1.66B	1.58B	1.63B	2.12B
Current Income Taxes Payable	-	-	-	26.6B	13.02B
Unearned Revenue Current, Total	7.61B	7.91B	8.06B	8.25B	9.06B
Other Current Liabilities	45.96B	59.18B	57.25B	50.07B	42.34B
Total Current Liabilities	125B	154B	145B	176B	166B
Long-Term Debt	109B	98.96B	95.28B	85.75B	78.33B
Long-Term Leases	10.28B	10.75B	11.27B	10.8B	11.6B
Unearned Revenue Non Current	-	-	-	-	-
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	43.05B	38.39B	38.58B	35.09B	29.95B
Total Liabilities	288B	302B	290B	308B	286B
Common Stock, Total	57.36B	64.85B	73.81B	83.28B	93.57B
Retained Earnings	5.56B	-3.07B	-214M	-19.15B	-14.26B
Comprehensive Income and Other	163M	-11.11B	-11.45B	-7.17B	-5.57B
Total Common Equity	63.09B	50.67B	62.15B	56.95B	73.73B
Total Equity	63.09B	50.67B	62.15B	56.95B	73.73B
Total Liabilities And Equity	351B	353B	353B	365B	359B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	16.41B	15.91B	15.55B	15.12B	14.78B
ECS Total Common Shares Outstanding	16.43B	15.94B	15.55B	15.12B	14.77B
Book Value / Share	3.84	3.18	4	3.77	4.99
Tangible Book Value	63.09B	50.67B	62.15B	56.95B	73.73B
Tangible Book Value Per Share	3.84	3.18	4	3.77	4.99
Total Debt	137B	132B	124B	119B	112B
Net Debt	-53.99B	-36.63B	-38.17B	-37.59B	-20.04B
Debt Equivalent Oper. Leases	117B	134B	127B	126B	146B
Account Code - Inventory Valuation	5	5	5	5	5
Land - (BS)	20.04B	22.13B	23.45B	24.69B	27.34B
Machinery, Total	78.66B	81.06B	78.31B	80.2B	83.42B
Full Time Employees	154K	164K	161K	164K	166K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: September	2021	2022	2023	2024	2025
Net Income	94.68B	99.8B	97B	93.74B	112B
Depreciation & Amortization - CF	11.28B	11.1B	11.52B	11.44B	11.7B
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	11.28B	11.1B	11.52B	11.44B	11.7B
Stock-Based Compensation (CF)	7.91B	9.04B	10.83B	11.69B	12.86B
Other Operating Activities, Total	-4.92B	1.01B	-2.23B	-2.27B	-89M
Change In Accounts Receivable	-10.12B	-1.82B	-1.69B	-3.79B	-6.68B
Change In Inventories	-2.64B	1.48B	-1.62B	-1.05B	1.4B
Change In Accounts Payable	12.33B	9.45B	-1.89B	6.02B	902M
Change in Unearned Revenues	1.68B	478M	-	-	-
Change in Other Net Operating Assets	-6.15B	-8.39B	-1.38B	2.46B	-20.62B
Cash from Operations	104B	122B	111B	118B	111B
Capital Expenditure	-11.08B	-10.71B	-10.96B	-9.45B	-12.72B
Cash Acquisitions	-33M	-306M	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-2.82B	-9.56B	16B	13.69B	29.39B
Other Investing Activities, Total	-608M	-1.78B	-1.34B	-1.31B	-1.48B
Cash from Investing	-14.54B	-22.35B	3.7B	2.94B	15.2B
Short Term Debt Issued, Total	1.02B	3.96B	-	3.96B	-
Long-Term Debt Issued, Total	20.39B	5.46B	5.23B	-	4.48B
Total Debt Issued	21.42B	9.42B	5.23B	3.96B	4.48B
Short Term Debt Repaid, Total	-	-	-3.98B	-	-2.03B
Long-Term Debt Repaid, Total	-8.75B	-9.54B	-11.15B	-9.96B	-10.93B
Total Debt Repaid	-8.75B	-9.54B	-15.13B	-9.96B	-12.96B
Issuance of Common Stock	1.1B	-	-	-	-
Repurchase of Common Stock	-92.53B	-95.62B	-82.98B	-100B	-96.67B
Common Dividends Paid	-14.47B	-14.84B	-15.02B	-15.23B	-15.42B
Common & Preferred Stock Dividends Paid	-14.47B	-14.84B	-15.02B	-15.23B	-15.42B
Other Financing Activities, Total	-129M	-160M	-581M	-361M	-111M
Cash from Financing	-93.35B	-111B	-108B	-122B	-121B
Net Change in Cash	-3.86B	-10.95B	5.76B	-794M	5.99B
Supplemental Items
Cash Interest Paid	2.69B	2.86B	3.8B	-	-
Cash Income Tax Paid (Refund)	25.38B	19.57B	18.68B	26.1B	43.37B
Levered Free Cash Flow	73.3B	90.22B	82.18B	111B	78.86B
Unlevered Free Cash Flow	74.95B	92.05B	84.64B	111B	78.86B
Change In Net Working Capital	1.25B	-7.96B	-1.81B	-20.15B	16.14B
Net Debt Issued / Repaid	12.66B	-123M	-9.9B	-6B	-8.48B

Fiscal Period: September	2021	2022	2023	2024	2025
Profitability
Return on Assets	20.18	21.21	20.26	21.46	22.96
Return on Total Capital	35.17	39	38.7	42.54	45.93
Return On Equity %	147.44	175.46	171.95	157.41	171.42
Return on Common Equity	147.44	175.46	171.95	157.41	171.42
Margin Analysis
Gross Profit Margin %	41.78	43.31	44.13	46.21	46.91
SG&A Margin	6.01	6.36	6.5	6.67	6.63
EBITDA Margin %	32.87	33.1	32.83	34.44	34.78
EBITA Margin %	29.78	30.29	29.82	31.51	31.97
EBIT Margin %	29.78	30.29	29.82	31.51	31.97
Income From Continuing Operations Margin %	25.88	25.31	25.31	23.97	26.92
Net Income Margin %	25.88	25.31	25.31	23.97	26.92
Net Avail. For Common Margin %	25.88	25.31	25.31	23.97	26.92
Normalized Net Income Margin	18.66	18.88	18.55	19.74	19.93
Levered Free Cash Flow Margin	20.04	22.88	21.44	28.35	18.95
Unlevered Free Cash Flow Margin	20.49	23.34	22.08	28.35	18.95
Asset Turnover
Asset Turnover	1.08	1.12	1.09	1.09	1.15
Fixed Assets Turnover	7.71	7.73	7.17	8.75	8.71
Receivables Turnover (Average Receivables)	17.26	14.48	13.29	12.43	11.37
Inventory Turnover (Average Inventory)	40.03	38.79	37.98	30.9	33.98
Short Term Liquidity
Current Ratio	1.07	0.88	0.99	0.87	0.89
Quick Ratio	0.91	0.71	0.84	0.75	0.77
Operating Cash Flow to Current Liabilities	0.83	0.79	0.76	0.67	0.67
Days Sales Outstanding (Average Receivables)	21.09	25.14	27.92	29.28	32.01
Days Outstanding Inventory (Average Inventory)	9.09	9.38	9.77	11.78	10.71
Average Days Payable Outstanding	81.97	97.5	109.07	113.32	115.16
Cash Conversion Cycle (Average Days)	-51.78	-62.98	-71.38	-72.26	-72.44
Long Term Solvency
Total Debt/Equity	216.39	261.45	199.42	209.06	152.41
Total Debt / Total Capital	68.39	72.33	66.6	67.64	60.38
LT Debt/Equity	189.22	216.5	171.45	169.53	121.97
Long-Term Debt / Total Capital	59.81	59.9	57.26	54.85	48.32
Total Liabilities / Total Assets	82.03	85.64	82.37	84.4	79.48
EBIT / Interest Expense	41.19	40.75	29.06	-	-
EBITDA / Interest Expense	50.98	50.27	36.03	-	-
(EBITDA - Capex) / Interest Expense	46.79	46.62	33.25	-	-
Total Debt / EBITDA	1.01	0.9	0.87	0.79	0.69
Net Debt / EBITDA	-0.4	-0.25	-0.27	-0.25	-0.12
Total Debt / (EBITDA - Capex)	1.1	0.97	0.95	0.84	0.75
Net Debt / (EBITDA - Capex)	-0.44	-0.27	-0.29	-0.27	-0.13
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	33.26	7.79	-2.8	2.02	6.43
Gross Profit, 1 Yr. Growth %	45.62	11.74	-0.96	6.82	8.04
EBITDA, 1 Yr. Growth %	55.45	8.57	-3.62	7.03	7.49
EBITA, 1 Yr. Growth %	64.36	9.63	-4.3	7.8	7.98
EBIT, 1 Yr. Growth %	64.36	9.63	-4.3	7.8	7.98
Earnings From Cont. Operations, 1 Yr. Growth %	64.92	5.41	-2.81	-3.36	19.5
Net Income, 1 Yr. Growth %	64.92	5.41	-2.81	-3.36	19.5
Normalized Net Income, 1 Yr. Growth %	62.77	9.06	-4.51	8.57	7.49
Diluted EPS Before Extra, 1 Yr. Growth %	71.04	8.91	0.33	-0.82	22.7
Accounts Receivable, 1 Yr. Growth %	63.01	7.25	4.7	13.22	19.06
Inventory, 1 Yr. Growth %	62.03	-24.83	28	15.08	-21.52
Net Property, Plant and Equip., 1 Yr. Growth %	9.24	6.07	3.51	4.5	9.09
Total Assets, 1 Yr. Growth %	8.37	0.5	-0.05	3.52	-1.57
Tangible Book Value, 1 Yr. Growth %	-3.44	-19.68	22.64	-8.36	29.47
Common Equity, 1 Yr. Growth %	-3.44	-19.68	22.64	-8.36	29.47
Cash From Operations, 1 Yr. Growth %	28.96	17.41	-9.5	6.98	-5.73
Capital Expenditures, 1 Yr. Growth %	51.66	-3.4	2.34	-13.8	34.59
Levered Free Cash Flow, 1 Yr. Growth %	21.37	23.09	-8.91	30.96	-28.85
Unlevered Free Cash Flow, 1 Yr. Growth %	20.53	22.81	-8.05	30.96	-28.85
Dividend Per Share, 1 Yr. Growth %	6.92	5.88	4.44	4.26	4.08
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	18.58	19.85	2.36	-0.42	4.2
Gross Profit, 2 Yr. CAGR %	24.63	27.56	5.2	2.86	7.43
EBITDA, 2 Yr. CAGR %	25.39	29.92	2.3	1.57	7.26
EBITA, 2 Yr. CAGR %	30.54	34.23	2.43	1.57	7.89
EBIT, 2 Yr. CAGR %	30.54	34.23	2.43	1.57	7.89
Earnings From Cont. Operations, 2 Yr. CAGR %	30.9	31.85	1.22	-3.09	7.46
Net Income, 2 Yr. CAGR %	30.9	31.85	1.22	-3.09	7.46
Normalized Net Income, 2 Yr. CAGR %	28.89	33.24	2.05	1.82	8.03
Diluted EPS Before Extra, 2 Yr. CAGR %	37.44	36.48	4.53	-0.25	10.32
Accounts Receivable, 2 Yr. CAGR %	7.06	32.23	5.97	8.88	16.1
Inventory, 2 Yr. CAGR %	26.59	10.36	-1.91	21.37	-4.96
Net Property, Plant and Equip., 2 Yr. CAGR %	15.11	7.65	4.78	-6.75	6.77
Total Assets, 2 Yr. CAGR %	1.83	4.36	0.22	1.72	0.94
Tangible Book Value, 2 Yr. CAGR %	-16.5	-11.94	-0.75	6.01	8.92
Common Equity, 2 Yr. CAGR %	-16.5	-11.94	-0.75	6.01	8.92
Cash From Operations, 2 Yr. CAGR %	22.45	23.05	3.08	-1.61	0.42
Capital Expenditures, 2 Yr. CAGR %	2.77	21.04	-0.57	-6.07	7.71
Levered Free Cash Flow, 2 Yr. CAGR %	30.69	22.23	5.89	9.74	-3.47
Unlevered Free Cash Flow, 2 Yr. CAGR %	28.84	21.67	6.27	9.74	-3.47
Dividend Per Share, 2 Yr. CAGR %	6.46	6.4	5.16	4.35	4.17
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	11.26	14.87	11.77	2.25	1.81
Gross Profit, 3 Yr. CAGR %	14.49	20.18	17.24	5.74	4.56
EBITDA, 3 Yr. CAGR %	13.7	19.51	17.61	3.85	3.5
EBITA, 3 Yr. CAGR %	15.4	23.16	19.91	4.19	3.66
EBIT, 3 Yr. CAGR %	15.4	23.16	19.91	4.19	3.66
Earnings From Cont. Operations, 3 Yr. CAGR %	16.73	21.78	19.1	-0.33	3.92
Net Income, 3 Yr. CAGR %	16.73	21.78	19.1	-0.33	3.92
Normalized Net Income, 3 Yr. CAGR %	14.42	21.91	19.24	4.18	3.68
Diluted EPS Before Extra, 3 Yr. CAGR %	23.48	27.18	23.18	2.72	6.88
Accounts Receivable, 3 Yr. CAGR %	4.26	7.13	22.33	8.33	12.17
Inventory, 3 Yr. CAGR %	18.48	6.4	15.95	3.46	4.95
Net Property, Plant and Equip., 3 Yr. CAGR %	6.24	12.01	6.25	-2.66	-1.74
Total Assets, 3 Yr. CAGR %	-1.36	1.38	2.87	1.31	0.61
Tangible Book Value, 3 Yr. CAGR %	-16.18	-17.58	-1.66	-3.36	13.32
Common Equity, 3 Yr. CAGR %	-16.18	-17.58	-1.66	-3.36	13.32
Cash From Operations, 3 Yr. CAGR %	10.35	20.74	11.07	4.36	-3
Capital Expenditures, 3 Yr. CAGR %	-5.92	0.67	14.46	-5.19	5.89
Levered Free Cash Flow, 3 Yr. CAGR %	15.57	28.1	10.82	14.78	-5.02
Unlevered Free Cash Flow, 3 Yr. CAGR %	14.82	26.8	10.82	13.93	-5.02
Dividend Per Share, 3 Yr. CAGR %	7.72	6.27	5.74	4.86	4.26
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.15	11.46	7.61	8.49	8.68
Gross Profit, 5 Yr. CAGR %	12.65	14.13	10.68	12.93	13.21
EBITDA, 5 Yr. CAGR %	11.26	12.79	8.99	11.98	13.35
EBITA, 5 Yr. CAGR %	12.66	14.25	10.02	14.02	14.95
EBIT, 5 Yr. CAGR %	12.66	14.25	10.02	14.02	14.95
Earnings From Cont. Operations, 5 Yr. CAGR %	15.69	15.6	10.26	11.15	14.3
Net Income, 5 Yr. CAGR %	15.69	15.6	10.26	11.15	14.3
Normalized Net Income, 5 Yr. CAGR %	12.22	13.2	9.3	13.44	14.62
Diluted EPS Before Extra, 5 Yr. CAGR %	21.98	21.55	15.52	15.41	17.86
Accounts Receivable, 5 Yr. CAGR %	10.77	9.54	4.94	7.82	19.8
Inventory, 5 Yr. CAGR %	25.28	0.37	9.86	12.15	7.08
Net Property, Plant and Equip., 5 Yr. CAGR %	12.89	9.23	5.65	4.09	1.91
Total Assets, 5 Yr. CAGR %	1.76	-1.23	-0.73	1.52	2.09
Tangible Book Value, 5 Yr. CAGR %	-12.01	-17.68	-10.32	-8.84	2.45
Common Equity, 5 Yr. CAGR %	-13.23	-17.68	-10.32	-8.84	2.45
Cash From Operations, 5 Yr. CAGR %	9.45	13.72	7.38	11.25	6.68
Capital Expenditures, 5 Yr. CAGR %	-2.74	-2.97	-3.82	-2.08	11.71
Levered Free Cash Flow, 5 Yr. CAGR %	10.72	17.89	11.6	20.9	5.48
Unlevered Free Cash Flow, 5 Yr. CAGR %	10.76	17.51	11.32	19.68	4.87
Dividend Per Share, 5 Yr. CAGR %	9.3	8.45	6.69	5.5	5.11